US Patent 11273155 Combination of antibody-drug conjugate and immune checkpoint inhibitor
Patent 11273155 was granted and assigned to Daiichi Sankyo on March, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Article (+620 characters)
Article
Patent abstract
A pharmaceutical composition and a therapeutic method wherein an antibody-drug conjugate and an immune checkpoint inhibitor are administered in combination, and the antibody-drug conjugate is an antibody-drug conjugate in which a drug-linker represented by the following formula (wherein A represents the connecting position to an antibody) is conjugated to the antibody via a thioether bond; and a pharmaceutical composition and a therapeutic method for use in treatment of a disease that can be ameliorated through an antitumor immunity-activating effect wherein the antibody-drug conjugate is included.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
112731550
Date of Patent
March 15, 2022
0Patent Application Number
164676140
Date Filed
December 11, 2017
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations
Golden AI
Infobox
Patent Citations
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
112731550
Date of Patent
March 15, 2022
0Patent Application Number
164676140
Date Filed
December 11, 2017
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 18 Mar, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
Edits on 16 Mar, 2022
Golden AI
Edits made to:
Infobox (+12 properties)
US Patent 11273155 Combination of antibody-drug conjugate and immune checkpoint inhibitor
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11273155
Date of patent
March 15, 2022
Patent application number
16467614
Date Filed
December 11, 2017
Patent citations
Patent primary examiner
Find more entities like US Patent 11273155 Combination of antibody-drug conjugate and immune checkpoint inhibitor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
